EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of MTAP and p16 immunohistochemical deficiency as surrogate marker for CDKN2A/B homozygous deletion in gliomas

Theoni Maragkou, Stefan Reinhard, Patric Jungo, Baptiste Pasquier, Maja Neuenschwander, Philippe Schucht, Erik Vassella, Ekkehard Hewer

Pathology · 2023

DOI: 10.1016/j.pathol.2023.01.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology, 2023. Verfasst von Theoni Maragkou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland. Electronic address: theoni.maragkou@unibe.ch. Hauptthemen laut MEDLINE: Oligodendroglioma, Glioma, Astrocytoma, Brain Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bern.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OligodendrogliomaGliomaAstrocytomaBrain NeoplasmsHumansCyclin-Dependent Kinase Inhibitor p16HomozygoteDNA Copy Number VariationsSequence DeletionGene DeletionBiomarkersPhosphorylasesIsocitrate DehydrogenaseMutation

Stichwörter der Autor:innen

CDKN2A/B homozygous deletionCNV plotGliomaMTAPp16

Substanzen

Cyclin-Dependent Kinase Inhibitor p16BiomarkersPhosphorylasesIsocitrate DehydrogenaseCDKN2A protein, human

Autor:innen und Institutionen

  • Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland. Electronic address: theoni.maragkou@unibe.ch.
  • Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.
  • Department of Neurosurgery, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
  • Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland; Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Förderung

  • University of Bern

Zitieren

APA

Maragkou, T., Reinhard, S., Jungo, P., Pasquier, B., Neuenschwander, M., Schucht, P., Vassella, E., & Hewer, E. (2023). Evaluation of MTAP and p16 immunohistochemical deficiency as surrogate marker for CDKN2A/B homozygous deletion in gliomas. Pathology. https://doi.org/10.1016/j.pathol.2023.01.005

Vancouver

Maragkou T, Reinhard S, Jungo P, Pasquier B, Neuenschwander M, Schucht P, et al. Evaluation of MTAP and p16 immunohistochemical deficiency as surrogate marker for CDKN2A/B homozygous deletion in gliomas. Pathology. 2023. doi:10.1016/j.pathol.2023.01.005

BibTeX
@article{Maragkou2023,
  author = {Maragkou, Theoni and Reinhard, Stefan and Jungo, Patric and Pasquier, Baptiste and Neuenschwander, Maja and Schucht, Philippe and Vassella, Erik and Hewer, Ekkehard},
  title = {Evaluation of MTAP and p16 immunohistochemical deficiency as surrogate marker for CDKN2A/B homozygous deletion in gliomas},
  journal = {Pathology},
  year = {2023},
  doi = {10.1016/j.pathol.2023.01.005}
}
Kostenlos starten →